InsidersTradesSigma
Follow the 威尔药业 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 威尔药业 has recorded 3 reports. Market capitalisation: €3.1bn. The latest transaction was disclosed on 24 March 2023 (Sale). Among the most active insiders: 王福秋. The full history is accessible without an account.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€819,071
3 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,723 of 28,685 companies
57.9
score / 100
Value61
Quality55
FCF yld5.9%
Earn yld4.8%
EV/EBITDA11.8x
ROE8.4%
Gross mgn28%
Net mgn11%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 March 2023
About 威尔药业
威尔药业 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and marketing of innovative pharmaceutical products.